GSK's revenue and EPS exceeded my expectations and those of analysts. Check out the reasons why I am upgrading GSK stock's ...
Thousands of U.S. health agency employees were terminated and told it was for poor performance, though they'd received strong ...
Gilead Sciences has won Food and Drug Administration priority review for its proposed lenacapavir twice-yearly shot to prevent HIV. Gilead on Tuesday said an FDA green light would make lenacapavir the ...
GlaxoSmithKline share price has surged more than 36% in two sessions after the announcement of Q3 results. The stock has ...
Opthea (OPT) has completed the final week 52 patient visit in COAST, the first of two Phase 3 pivotal trials investigating the superiority and ...
Swim Across America, a national nonprofit dedicated to funding cancer research and patient programs through funds raised with ...
The study's results are particularly noteworthy as they were part of a multi-center, randomized, double-blind, placebo-controlled trial involving approximately 250 patients across roughly 40 clinical ...
Johnson & Johnson is well-diversified across thriving healthcare segments, with promising FDA approvals. Read why I assign a ...
US Dollar Index Futures, Bitcoin US Dollar, Solana US Dollar, Robinhood Markets Inc. Read The Tokenist (Timothy Fries)'s Market Analysis on Investing.com India ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback